{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:24:37Z","timestamp":1759332277790},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Critical Care"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.jcrc.2012.11.007","type":"journal-article","created":{"date-parts":[[2013,1,20]],"date-time":"2013-01-20T01:30:22Z","timestamp":1358645422000},"page":"882.e1-882.e11","source":"Crossref","is-referenced-by-count":9,"title":["Serum concentrations of A Proliferation-Inducing Ligand (APRIL) are elevated in sepsis and predict mortality in critically ill patients"],"prefix":"10.1016","volume":"28","author":[{"given":"Christoph","family":"Roderburg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Koch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Tacke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lukas","family":"Nieuwenhuijsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Bruensing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Vargas Cardenas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karina","family":"Kreggenwinkel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihael","family":"Vucur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christiane","family":"Koppe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Jungebluth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Seikrit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Luedde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Trautwein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"Luedde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcrc.2012.11.007_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2567.2005.02143.x","article-title":"The intriguing biology of the tumour necrosis factor\/tumour necrosis factor receptor superfamily: players, rules and the games","volume":"115","author":"Hehlgans","year":"2005","journal-title":"Immunology"},{"key":"10.1016\/j.jcrc.2012.11.007_bb0010","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1515\/BC.2002.178","article-title":"The TNF-TNF receptor system","volume":"383","author":"Hehlgans","year":"2002","journal-title":"Biol Chem"},{"key":"10.1016\/j.jcrc.2012.11.007_bb0015","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1126\/science.282.5392.1281","article-title":"An essential role for ectodomain shedding in mammalian development","volume":"282","author":"Peschon","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.jcrc.2012.11.007_bb0020","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/nri1184","article-title":"Signalling pathways of the TNF superfamily: a double-edged sword","volume":"3","author":"Aggarwal","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jcrc.2012.11.007_bb0025","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1378\/chest.125.6.2238","article-title":"Serum levels of the apoptosis-associated molecules, tumor necrosis factor-alpha\/tumor necrosis factor type-I receptor and Fas\/FasL, in sepsis","volume":"125","author":"De Freitas","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.jcrc.2012.11.007_bb0030","doi-asserted-by":"crossref","unstructured":"Pierrakos C, Vincent JL. Sepsis biomarkers: a review. Crit Care 14:R15.","DOI":"10.1186\/cc8872"},{"key":"10.1016\/j.jcrc.2012.11.007_bb0035","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s00251-009-0395-6","article-title":"Mortality in adult intensive care patients with severe systemic inflammatory response syndromes is strongly associated with the hypo-immune TNF-238A polymorphism","volume":"61","author":"Pappachan","year":"2009","journal-title":"Immunogenetics"},{"key":"10.1016\/j.jcrc.2012.11.007_bb0040","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1744-313X.2008.00773.x","article-title":"Characterization of tumour necrosis factor-alpha genetic variants and mRNA expression in patients with severe sepsis","volume":"35","author":"O'Dwyer","year":"2008","journal-title":"Int J Immunogenet"},{"key":"10.1016\/j.jcrc.2012.11.007_bb0045","doi-asserted-by":"crossref","first-page":"829","DOI":"10.2174\/156652408786733711","article-title":"The expanding role of APRIL in cancer and immunity","volume":"8","author":"Planelles","year":"2008","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.jcrc.2012.11.007_bb0050","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1084\/jem.188.6.1185","article-title":"APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth","volume":"188","author":"Hahne","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.jcrc.2012.11.007_bb0055","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/400_2008_19","article-title":"APRIL in B-cell malignancies and autoimmunity","volume":"49","author":"Kimberley","year":"2009","journal-title":"Results Probl Cell Differ"},{"key":"10.1016\/j.jcrc.2012.11.007_bb0060","doi-asserted-by":"crossref","first-page":"3903","DOI":"10.1073\/pnas.0307348101","article-title":"Impaired IgA class switching in APRIL-deficient mice","volume":"101","author":"Castigli","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jcrc.2012.11.007_bb0065","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1172\/JCI31023","article-title":"Dominant-negative effect of the heterozygous C104R TACI mutation in common variable immunodeficiency (CVID)","volume":"117","author":"Garibyan","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jcrc.2012.11.007_bb0070","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/ng1601","article-title":"TACI is mutant in common variable immunodeficiency and IgA deficiency","volume":"37","author":"Castigli","year":"2005","journal-title":"Nat Genet"},{"key":"10.1016\/j.jcrc.2012.11.007_bb0075","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1136\/ard.2004.022491","article-title":"Raised serum APRIL levels in patients with systemic lupus erythematosus","volume":"64","author":"Koyama","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jcrc.2012.11.007_bb0080","doi-asserted-by":"crossref","first-page":"R167","DOI":"10.1186\/ar2076","article-title":"Differential effects on BAFF and APRIL levels in rituximab-treated patients with systemic lupus erythematosus and rheumatoid arthritis","volume":"8","author":"Vallerskog","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jcrc.2012.11.007_bb0085","doi-asserted-by":"crossref","unstructured":"Tecchio C, Nichele I, Mosna F, et al. A proliferation-inducing ligand (APRIL) serum levels predict time to first treatment in patients affected by B-cell chronic lymphocytic leukemia. Eur J Haematol 87:228-34.","DOI":"10.1111\/j.1600-0609.2011.01650.x"},{"key":"10.1016\/j.jcrc.2012.11.007_bb0090","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.clinbiochem.2008.05.005","article-title":"High C5a levels are associated with increased mortality in sepsis patients\u2014no enhancing effect by actin-free Gc-globulin","volume":"41","author":"Gressner","year":"2008","journal-title":"Clin Biochem"},{"key":"10.1016\/j.jcrc.2012.11.007_bb0095","doi-asserted-by":"crossref","unstructured":"Koch A, Voigt S, Kruschinski C, et al. Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients. Crit Care 15:R63.","DOI":"10.1186\/cc10037"},{"key":"10.1016\/j.jcrc.2012.11.007_bb0100","doi-asserted-by":"crossref","unstructured":"Koch A, Voigt S, Sanson E, et al. Prognostic value of circulating amino-terminal pro-C\u2013type natriuretic peptide in critically ill patients. Crit Care 15:R45.","DOI":"10.1186\/cc10007"},{"key":"10.1016\/j.jcrc.2012.11.007_bb0105","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/01.CCM.0000298158.12101.41","article-title":"Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008","volume":"36","author":"Dellinger","year":"2008","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jcrc.2012.11.007_bb0110","unstructured":"Reinhart K, Brunkhorst FM, Bone HG, et al. Prevention, diagnosis, therapy and follow-up care of sepsis: 1st revision of S-2k guidelines of the German Sepsis Society (Deutsche Sepsis-Gesellschaft e.V. (DSG)) and the German Interdisciplinary Association of Intensive Care and Emergency Medicine (Deutsche Interdisziplinare Vereinigung fur Intensiv- und Notfallmedizin (DIVI)). Ger Med Sci 8:Doc14."},{"key":"10.1016\/j.jcrc.2012.11.007_bb0115","doi-asserted-by":"crossref","unstructured":"Parameswaran N, Patial S. Tumor necrosis factor-alpha signaling in macrophages. Crit Rev Eukaryot Gene Expr 20:87-103.","DOI":"10.1615\/CritRevEukarGeneExpr.v20.i2.10"},{"key":"10.1016\/j.jcrc.2012.11.007_bb0120","doi-asserted-by":"crossref","first-page":"L622","DOI":"10.1152\/ajplung.00477.2005","article-title":"NF-kappa B activation as a pathological mechanism of septic shock and inflammation","volume":"290","author":"Liu","year":"2006","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.jcrc.2012.11.007_bb0125","doi-asserted-by":"crossref","unstructured":"Rauch PJ, Chudnovskiy A, Robbins CS, et al. Innate response activator B cells protect against microbial sepsis. Science 335:597-601.","DOI":"10.1126\/science.1215173"},{"key":"10.1016\/j.jcrc.2012.11.007_bb0130","doi-asserted-by":"crossref","unstructured":"Nagai M, Hirayama K, Ebihara I, et al. Serum levels of BAFF and APRIL in myeloperoxidase anti-neutrophil cytoplasmic autoantibody-associated renal vasculitis: association with disease activity. Nephron Clin Pract 118:c339-45.","DOI":"10.1159\/000323393"},{"key":"10.1016\/j.jcrc.2012.11.007_bb0135","doi-asserted-by":"crossref","unstructured":"Nagai M, Hirayama K, Ebihara I, et al. Serum TNF-related and weak inducer of apoptosis levels in septic shock patients. Ther Apher Dial 15:342-8.","DOI":"10.1111\/j.1744-9987.2011.00966.x"},{"key":"10.1016\/j.jcrc.2012.11.007_bb0140","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0140-6736(00)80009-4","article-title":"Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II Study Group","volume":"351","author":"Abraham","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jcrc.2012.11.007_bb0145","doi-asserted-by":"crossref","unstructured":"Gaieski DF, Mikkelsen ME, Band RA, et al. Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department. Crit Care Med 38:1045-53.","DOI":"10.1097\/CCM.0b013e3181cc4824"},{"key":"10.1016\/j.jcrc.2012.11.007_bb0150","doi-asserted-by":"crossref","first-page":"R95","DOI":"10.1186\/cc7925","article-title":"Serum resistin levels in critically ill patients are associated with inflammation, organ dysfunction and metabolism and may predict survival of non-septic patients","volume":"13","author":"Koch","year":"2009","journal-title":"Crit Care"}],"container-title":["Journal of Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883944112004741?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883944112004741?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T11:29:21Z","timestamp":1539948561000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0883944112004741"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0883944112004741"],"URL":"https:\/\/doi.org\/10.1016\/j.jcrc.2012.11.007","relation":{},"ISSN":["0883-9441"],"issn-type":[{"value":"0883-9441","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]}}}